Immix Biopharma
IMMX
IMMX
31 hedge funds and large institutions have $5.78M invested in Immix Biopharma in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.48% more ownership
Funds ownership: 8.11% → 9.59% (+1.5%)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$215K | |
| 2 | +$170K | |
| 3 | +$134K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$132K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$96.1K |
Top Sellers
| 1 | -$37K | |
| 2 | -$28.9K | |
| 3 | -$23K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$11K |
| 5 |
Morgan Stanley
New York
|
-$10.2K |
